Are high initial doses of olanzapine required to reduce agitation associated with schizophrenia?
Townsend
Mark H
MH
Baier
Margaret B
MB
D000284:Administration, Oral; D014150:Antipsychotic Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D001569:Benzodiazepines; D039721:Diagnostic and Statistical Manual of Mental Disorders; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D005260:Female; D006801:Humans; D007273:Injections, Intramuscular; D008297:Male; D000077152:Olanzapine; D011595:Psychomotor Agitation / Q000150:complications* / Q000175:diagnosis / Q000188:drug therapy*; D012559:Schizophrenia / Q000150:complications* / Q000175:diagnosis / Q000188:drug therapy*
D014150:Antipsychotic Agents; D001569:Benzodiazepines; D000077152:Olanzapine